The regional localization of a new potent centrally acting antihypertensive agent R 28935 and its less active threo isomer R 29814 in the cat brain

A.J.M. Loonen, W. Soudijn, H.H. Van Rooy, I. Van Wijngaarden

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
9 Downloads (Pure)

Abstract

Systemic administration of the centrally acting antihypertensive agent R 28935 to cats resulted in a long lasting decrease of mean arterial pressure (±30%) whereas the same dose of the threo-isomer R 29814 was ineffective. The antihypertensive activity was due to the unaltered drug. In spite of an identical log P, pKa, dose and a comparable plasma level, the concentration of R 28935 in all the brain areas tested was about twice that of the threo-isomer, suggesting a stereoselective uptake and/or binding of R 28935.
Original languageEnglish
Pages (from-to)281-285
Number of pages5
JournalEuropean Journal of Pharmacology
Volume45
Issue number3
DOIs
Publication statusPublished - 22-Apr-1977
Externally publishedYes

Keywords

  • 1 [1 [2 (1,4 benzodioxan 2 yl) 2 hydroxyethyl] 4 piperidyl] 2 benzimidazolinone
  • radioisotope
  • tritium
  • unclassified drug
  • blood pressure
  • brain
  • cat
  • drug absorption
  • drug binding
  • drug distribution
  • drug isomer
  • erythro 1 {1 [2 (2,3 dihydro 1,4 benzodioxin 2 yl) 2 hydroxyethyl] 4 piperidinyl} 1,3 dihydro 2h benzimidazol 2 one h 3
  • pharmacokinetics
  • plasma
  • stereochemistry
  • theoretical study
  • threo 1 {1 [2 (2,3 dihydro 1,4 benzodioxin 2 yl) 2 hydroxyethyl] 4 piperidinyl} 1,3 dihydro 2h benzimidazol 2 one h 3

Fingerprint

Dive into the research topics of 'The regional localization of a new potent centrally acting antihypertensive agent R 28935 and its less active threo isomer R 29814 in the cat brain'. Together they form a unique fingerprint.

Cite this